UP

Cancer immunotherapy drug 'less toxic and prolongs life'

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
Cancer immunotherapy drug 'less toxic and prolongs life'

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say.

Axar.az reports citing BBC.

In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years - five times longer than under chemotherapy.

The patients also suffered far fewer side-effects.

Cases of head and neck cancers are rising in the UK and most are diagnosed late, when they are hard to treat.

Date
2019.11.23 / 21:56
Author
Axar.az
See also

Avoid alcohol in autumn to protect your immunity

Uzbek, Kazakh doctors perform robotic surgery in Tashkent

WHO warns of dangerous India-made cough syrups

Azerbaijan receives Sanofi influenza vaccines

Scientists develop a drug that trains the immune system

Early smoking increases cancer risk up to 4 times

Chikungunya fever is spreading rapidly in South China

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla